Cite
HARVARD Citation
Prandoni, P. et al. (2018). Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin. Thrombosis research. pp. 121-129. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Prandoni, P. et al. (2018). Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin. Thrombosis research. pp. 121-129. [Online].